Respiratory Tract Infections News and Research

RSS

Bisphosphonates appear to improve COVID-19 exposure outcomes

A new retrospective study examines the effect of bisphosphonates on COVID-19 outcomes.

27 Jun 2022

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

AbbVie today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of upadacitinib (RINVOQ® 15 mg, once daily) for the treatment of active non-radiographic axial spondyloarthritis (nr‑axSpA) in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs).*

27 Jun 2022

COVID-19 patients have increased risk of new‐onset psychiatric disorders after infection

A recent Oregon State University study found that COVID-19 patients had a roughly 25% increased risk of developing a psychiatric disorder in the four months following their infection, compared with people who had other types of respiratory tract infections.

6 Jun 2022

2-Deoxy-D-glucose may inhibit coronaviruses and rhinoviruses

Scientists demonstrated the use of 2-deoxy-D-glucose (2-DG) as a wide-spectrum antiviral agent targeting viruses such as SARS-CoV-2.

27 May 2022

Study examines vitamin D and COVID-19 media coverage in the U.K.

A new study investigates the relationship between COVID-19 and vitamin D that has been presented in traditional media sources like U.K. newspapers.

20 Apr 2022

Study examines pediatric emergency department attendance trends during the first COVID-19 wave in Europe

Researchers investigated the impact of SARS-CoV-2 infection and the adoption of preventive measures in pediatric emergency department attendances in Europe.

30 Mar 2022

Human parainfluenza type 3 virus outbreak in Seoul during SARS-CoV-2 pandemic

In a recent study posted to the bioRxiv* preprint server, researchers conducted a phylogenetic investigation of the human parainfluenza type 3 virus strain (HPIV3) that caused an outbreak in South Korea amid the coronavirus disease 2019 (COVID-19) pandemic.

22 Mar 2022

Covid-19 patients are at increased risk of developing type 2 diabetes, study shows

People who have had Covid-19 are at increased risk of developing type 2 diabetes. This is the result of a study by DDZ, DZD and IQVIA, which has now been published in Diabetologia.

21 Mar 2022

Diabetes incidence after infection with COVID-19

Researchers investigated the incidence of diabetes among COVID-19 cases.

21 Mar 2022

Vaccine effectiveness against COVID-19 severity in the elderly

Researchers assessed vaccine effectiveness against SARS-CoV-2 infection in elderly patients before and after the spread of the SARS-CoV-2 Omicron variant of concern.

17 Mar 2022

Study finds a causal link between deforestation and reduction in people's dietary quality

Current policies for guaranteeing food security emphasize the importance of farmland, but forests play critical roles as well.

16 Mar 2022

Antimicrobial prescribing among infants may be prevented using maternal RSV vaccines

RSV is a leading cause of severe acute lower respiratory tract infections (LRTIs) among infants globally, and a prominent contributor to common non-severe infections that account for high volumes of antibiotic consumption.

14 Mar 2022

Single dose of new drug nirsevimab provides safe protection against RSV in healthy infants

The new drug nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomized, placebo-controlled phase 3 clinical trial published in the New England Journal of Medicine.

9 Mar 2022

Gas chromatography-ion mobility spectrometry helps diagnose COVID-19 and predict disease severity

Researchers assess the ability of GC-IMS to differentiate between COVID-19 and other respiratory infections, as well as predict disease severity.

4 Mar 2022

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

Nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomized, placebo-controlled Phase 3 clinical trial.

3 Mar 2022

High nasopharyngeal viral load in SARS-CoV-2 Omicron-induced infection

In a recent study posted to the Research Square* pre-print server, a team of researchers from Italy and the United States (US) retrospectively reviewed and compared viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron and previous SARS-CoV-2 strain-induced infection.

23 Feb 2022

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

The current study examined the incidence of COVID-19 in children with ARI relative to other respiratory viruses during the second and third waves.

22 Feb 2022

Study shows SARS-CoV-2 infection can change nasopharyngeal microbiota composition in pregnancy

A recent study from Spain showed that the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can change the overall structure and diversity of the nasopharyngeal microbiota in pregnant women – which persists even weeks after clinical infection. The paper is currently available on Research Square preprint* server.

3 Feb 2022

Exploring human milk oligosaccharides as a method of COVID-19 prevention

New research was conducted to ascertain whether antiviral and immunomodulatory activities of human milk oligosaccharides can be efficacious in the prevention and treatment against COVID-19.